New data reinforce daratumumab as standard of care for multiple myeloma - PharmaTimes Long-term survival projections suggest improved outcomes for patients

#Haematology #Oncology #daratumumab #multiplemyeloma #JanssenCilag #JnJInnovativeMedicine #subcutaneousDARZALEX #DARZALEX #daratumumab #PERSEUSclinicaltrial #CEPHEUSclinicaltrial #daratumumabVRd #VRdwithoutdaratumumab #PERSEUSregimen #daratumumabVRdwithmaintenancetherapy
zurl.co/1ZoEc